Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation.
about
Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation.HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathyInfection of cells expressing CXCR4 mutants lacking N-glycosylation at the N-terminal extracellular domain is enhanced for R5X4-dualtropic human immunodeficiency virus type-1.The biology of CCR5 and CXCR4NMR structural analysis of a peptide mimic of the bridging sheet of HIV-1 gp120 in methanol and water.Identification of CXCR4 domains that support coreceptor and chemokine receptor functionsProduction and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptorCharacterization of gp120 and its single-chain derivatives, gp120-CD4D12 and gp120-M9: implications for targeting the CD4i epitope in human immunodeficiency virus vaccine design.Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120.Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor.Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles.Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.The HIV-1 Gp120/CXCR4 axis promotes CCR7 ligand-dependent CD4 T cell migration: CCR7 homo- and CCR7/CXCR4 hetero-oligomer formation as a possible mechanism for up-regulation of functional CCR7.In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120.Improving HIV proteome annotation: new features of BioAfrica HIV Proteomics Resource.CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptorHuman Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation.Endocytic Trafficking of HIV gp120 is Mediated by Dynamin and Plays a Role in gp120 Neurotoxicity.CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses.T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infectionEffect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses.CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes.The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors.A replication-competent, neutralization-sensitive variant of simian immunodeficiency virus lacking 100 amino acids of envelope.Human monoclonal antibody 2909 binds to pseudovirions expressing trimers but not monomeric HIV-1 envelope proteinsHIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.CD4:gp120 binds to chemokine co-receptor CCR5/CXCR4
P2860
Q24529180-315FAFAD-B59F-4236-ADCC-39E41DCEAF3CQ24563955-E7676478-04F9-412F-A598-37AC01C82A63Q24794092-175566F7-7CDF-4F34-BDEC-2B0251F330D5Q29012920-5391747F-1396-4BC3-9D0C-AA09EFA52352Q30989881-D2DF6FEE-1996-4E53-817D-68641FDF0963Q33643223-ACA018E8-BE1B-4874-B334-7EB71A1EBD09Q33644217-8F45A3AA-D2A2-4159-8D23-BBD7B1CE48E9Q33717477-38BB0635-44C7-4DCD-95C0-9D1A89206B7DQ33783714-1E4ADF1B-ED7B-48AA-BCD1-E0602280129AQ33787329-F066D03F-62F8-48C4-A056-AA4B2E45A822Q33794954-485B7DD7-9370-4203-8E81-8E69AF35BFE6Q33809112-6A201E21-AC63-4EC6-A461-C005F6B98486Q33825418-0AA1AE54-B663-4970-AAA7-FB1CFAD9B580Q33835427-85AB02B8-6287-4188-AEB5-DD2B4EFFF463Q34332519-9CACDAAE-01C6-4AB9-ABE5-D4F37E60B43DQ34406977-F59BD097-6071-46B4-9F1E-261E996FB984Q34756144-6702D08B-BEC5-4A5F-911D-696BFA2D9EF1Q35092369-9BA5FAA6-1F0C-4A88-BAA6-20B205C67CE5Q36529013-7D34ADC0-0A4A-476F-92E3-B02F177C186EQ36805433-50C3A4FD-B869-4244-B2E6-00679F5A381AQ37730009-B560959C-9818-4A14-AC94-CD8F1487B6AAQ38659327-5FB3073D-97D0-4120-8275-E5FF03FFC79BQ38872070-2FBA3FA0-F1D1-40F8-8939-23A82CAE5A05Q38915583-63339B37-537B-4D4B-9AA5-F7A459025D63Q39422872-9C615FDB-C8A6-417A-83DE-C851FA8BBFC8Q39549670-1D7C5D52-0AB2-477C-828B-09EE9DFBAC68Q39550956-7024C661-CDB9-4AFA-8AB3-6B626C757122Q39563512-34AC202D-8C44-4E58-B15A-0AFCD87181A9Q39597685-0AD93E41-C5C9-4330-B38D-940FEEF0C4BBQ39682625-AB824BF3-D7D8-453F-81DA-6BB9F418BE22Q39845715-F0FE22F1-31AE-4D08-926E-E2650A883C41Q47547483-A4E015A0-BFF7-4ECF-BA97-D43C00334E6CQ50289259-9A85F837-E9B9-4315-A874-5171F5A8DAE5
P2860
Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Human immunodeficiency virus ( ...... y HIV envelope deglycosylation
@nl
Human immunodeficiency virus ( ...... HIV envelope deglycosylation.
@ast
Human immunodeficiency virus ( ...... HIV envelope deglycosylation.
@en
type
label
Human immunodeficiency virus ( ...... y HIV envelope deglycosylation
@nl
Human immunodeficiency virus ( ...... HIV envelope deglycosylation.
@ast
Human immunodeficiency virus ( ...... HIV envelope deglycosylation.
@en
prefLabel
Human immunodeficiency virus ( ...... y HIV envelope deglycosylation
@nl
Human immunodeficiency virus ( ...... HIV envelope deglycosylation.
@ast
Human immunodeficiency virus ( ...... HIV envelope deglycosylation.
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus ( ...... y HIV envelope deglycosylation
@en
P2093
J C Bandres
S Zolla-Pazner
P2860
P304
P577
1998-03-01T00:00:00Z